reference/27145887

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27145887

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	53
issn	1473-4230 1473-4222
issueIdentifier	1
pageRange	41-53
publicationName	Cerebellum (London, England)
startingPage	41
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_65d2a0d5471be77da085e84668a9588c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a64433b8f7c8ffbf4e54aeaf74159986 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9238383fd6fa5ac1c5b34ac607ca378d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_928b434795eb499d2ad615bddfd906a5 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_befc2025f381ee10d41ce27c8a3602ff http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f0812d1e148a00d811334f8b05c66b00
bibliographicCitation	Bushart DD, Zalon AJ, Zhang H, Morrison LM, Guan Y, Paulson HL, Shakkottai VG, McLoughlin HS. Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel–Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3. The Cerebellum. 2020 Aug 13;20(1):41–53. doi: 10.1007/s12311-020-01179-7.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9342f0ca1a0e8189e94a7886ad88aacd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8e4a53a11ee440be90f2f5cd04cfdea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e5b509c1465aeb151d328c2e12c41fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbb3e542c4365d95000bd23c82529a3d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4279-2758 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5451f3889c674d3c9ba4c4fbfa816102 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4aae062fb325a9c94da9397ed1102ca5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf6db33d651e588d2a3dba8e08bf8b75
date	2020-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC7930886 https://doi.org/10.1007/s12311-020-01179-7 https://pubmed.ncbi.nlm.nih.gov/32789747
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30404 https://portal.issn.org/resource/ISSN/1473-4222 https://portal.issn.org/resource/ISSN/1473-4230
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel–Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3
discusses	http://id.nlm.nih.gov/mesh/M0018809 http://id.nlm.nih.gov/mesh/M000600684 http://id.nlm.nih.gov/mesh/M0236736 http://id.nlm.nih.gov/mesh/M0243749 http://id.nlm.nih.gov/mesh/M0025055 http://id.nlm.nih.gov/mesh/M0264045 http://id.nlm.nih.gov/mesh/M0470133 http://id.nlm.nih.gov/mesh/M0371348 http://id.nlm.nih.gov/mesh/M0177383
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5485b87bc33b24794e5d39b1e293abc7 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6989 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16133899 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3b57bc422d980fad6570eaa080f05dd8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10090 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9279 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c9c59792437aeed2c2cedf9fa33abdb1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_450fff9e97c0e951b2aa743a3a6c027f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7206 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5961

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4287

Total number of triples: 57.